Table Of Content

Adnexal masses surgical considerations for valvular heart disease, diagnostic evaluation, 577-580 634 follow-up of adnexal masses, 580 acute prosthetic valve dysfunction, 636-638 tumor markers, 581 aortic stenosis, 636 management mitral stenosis, 634-636 cyst aspiration, 581 surgically corrected congenital heart disease, expectant management, 581 641-644 incidental mass discovered at cesarean, 583 Cerclage in pregnancy obstetrical considerations and perinatal does a cerclage need to be carried out in outcomes, 582-583 subsequent pregnancy after previously progesterone supplementation, 583 successful pregnancy? 607-608 surgical resection, 581-582 historical risks suggesting high risk for cervical ovarian cancer in pregnancy, 583-584 insufficiency and history indicated cerclage, potential scenarios 599-600 benign “‘functional’’ masses, 572 574 physical examination- indicated cerclage, 602 benign neoplasms, 574-575 recurrent premature birth or second trimester loss malignancy, 576-577 despite cerclage: transabdominal mass effect, 576 cervicoisthmic cerclage (TAC), 602-603 spontaneous resolution, 571-572 risks of history indicated vaginal cerclage, 600 torsion, 575-576 should a cerclage be removed in the face of in pregnancy ruptured membranes? 607 incidence, 571 should a cerclage that has slipped be replaced? Anesthesia for nonobstetric surgery 606-607 cardiac surgery, 542 surgical technique clinical suggestions, 543-544 TAC, 606 evidence that anesthetics may influence fetal transvaginal approach, 603-606 neonatal development, 539-541 syndromic phenomena of cervical change, fertility and pregnancy retention, 541 598-599 fetal monitoring, 541 ultrasound indicated vaginal cerclage, 601-602 fetal surgery, 542-544 fetal vulnerability to teratogenicity, 537-539 Female sexual arousal disorder, diagnosis and laparoscopy, 542 treatment of, 675-678 operating room personnel and anesthetic treatment, 678-680 exposure, 541 Fetoscopic management of complicated physiologic changes of pregnancy, 536-537 monochorionic twins, 647 trauma, 542 SIUGR, 651-652 Appendicitis and cholecystitis in pregnancy TRAP sequence, 650-651 appendicitis, 586-589 TTTS, 648-650 cholecystitis, 589-592 radiologic imaging considerations, 592-594 surgical considerations, 594 Hypoactive sexual desire disorder, diagnosis and treatment of aging and declining androgens in women, Cardiac surgery in pregnancy 667-668 aortic dissection and aortic aneurysm, 638-639 aging and declining sexual desire, 668 cardiopulmonary bypass in pregnancy, 640-641 androgens, aging, and sexual desire, 667 cardiovascular adaptation to pregnancy, 631-632 custom formulated gels and creams for women, considerations for labor and delivery, 644-645 671 ischemic heart disease, coronary artery disease, diagnosis, 666-667 639 intramuscular testosterone, 671 predicting outcomes for surgical cardiac disease oral androgens, 671 in pregnancy, 632-634 dehydroepiniandrosterone, 672 CLINICAL OBSTETRICS AND GYNECOLOGY VOLUME 52 NUMBER 4 DECEMBER 2009 712 Adnexal masses surgical considerations for valvular heart disease, diagnostic evaluation, 577-580 634 follow-up of adnexal masses, 580 acute prosthetic valve dysfunction, 636-638 tumor markers, 581 aortic stenosis, 636 management mitral stenosis, 634-636 cyst aspiration, 581 surgically corrected congenital heart disease, expectant management, 581 641-644 incidental mass discovered at cesarean, 583 Cerclage in pregnancy obstetrical considerations and perinatal does a cerclage need to be carried out in outcomes, 582-583 subsequent pregnancy after previously progesterone supplementation, 583 successful pregnancy? 607-608 surgical resection, 581-582 historical risks suggesting high risk for cervical ovarian cancer in pregnancy, 583-584 insufficiency and history indicated cerclage, potential scenarios 599-600 benign “‘functional’’ masses, 572 574 physical examination- indicated cerclage, 602 benign neoplasms, 574-575 recurrent premature birth or second trimester loss malignancy, 576-577 despite cerclage: transabdominal mass effect, 576 cervicoisthmic cerclage (TAC), 602-603 spontaneous resolution, 571-572 risks of history indicated vaginal cerclage, 600 torsion, 575-576 should a cerclage be removed in the face of in pregnancy ruptured membranes? 607 incidence, 571 should a cerclage that has slipped be replaced? Anesthesia for nonobstetric surgery 606-607 cardiac surgery, 542 surgical technique clinical suggestions, 543-544 TAC, 606 evidence that anesthetics may influence fetal transvaginal approach, 603-606 neonatal development, 539-541 syndromic phenomena of cervical change, fertility and pregnancy retention, 541 598-599 fetal monitoring, 541 ultrasound indicated vaginal cerclage, 601-602 fetal surgery, 542-544 fetal vulnerability to teratogenicity, 537-539 Female sexual arousal disorder, diagnosis and laparoscopy, 542 treatment of, 675-678 operating room personnel and anesthetic treatment, 678-680 exposure, 541 Fetoscopic management of complicated physiologic changes of pregnancy, 536-537 monochorionic twins, 647 trauma, 542 SIUGR, 651-652 Appendicitis and cholecystitis in pregnancy TRAP sequence, 650-651 appendicitis, 586-589 TTTS, 648-650 cholecystitis, 589-592 radiologic imaging considerations, 592-594 surgical considerations, 594 Hypoactive sexual desire disorder, diagnosis and treatment of aging and declining androgens in women, Cardiac surgery in pregnancy 667-668 aortic dissection and aortic aneurysm, 638-639 aging and declining sexual desire, 668 cardiopulmonary bypass in pregnancy, 640-641 androgens, aging, and sexual desire, 667 cardiovascular adaptation to pregnancy, 631-632 custom formulated gels and creams for women, considerations for labor and delivery, 644-645 671 ischemic heart disease, coronary artery disease, diagnosis, 666-667 639 intramuscular testosterone, 671 predicting outcomes for surgical cardiac disease oral androgens, 671 in pregnancy, 632-634 dehydroepiniandrosterone, 672 CLINICAL OBSTETRICS AND GYNECOLOGY VOLUME 52 NUMBER 4 DECEMBER 2009 712 methyltestosterone, 672 psychologic aspect, 685 micronized testosterone, 672 treatment prevalence and clinical course, 667 deep dyspareunia, 686 regulatory issues, 673 superficial dyspareunia, 686-688 restoring sexual desire with testosterone, 668-669 Sexual ramifications of medical illness safety issues in prescribing testosterone to evaluation of patients for sexual dysfunction, women, 672-673 695-696 subcutaneous, 671 sexual dysyfunction and cancer, 693-694 testosterone matrix patches for men (off-label), sexual health and cardiovascular disease, 691-692 671 sexual problems and endocrine disease, 692-693 testosterone matrix patches for women, 669-671 treatment options for sexual dysfunction, 696-699 testosterone products in development, 672 Surgery in obese pregnant patients transdermal testosterone gels and creams for men anesthesia, 548-549 (off-label), 671 bariatric surgery, 55: definition, 547 Impact of rape on female sexuality, 702-703 fetal monitoring, 549-550 method intraoperative complications, 549 data sources, 703 lifestyle modification, 551-552 study eligibility, 703—704 obesity epidemic, 546-547 study selection, 704 pharmacotherapeutic options, 552 results postoperative complications, 550 genital injury and sexually transmitted diseases, pregnancy after bariatric surgery, 55 704-708 preoperative issues, 547-548 intersection of psychologic functioning and prepregnancy weight loss sexual health concerns, 709 nonsurgical weight loss options, 55 reproductive and sexual functioning, 708 Surgical intervention in pregnancy, 53: sexual behaviors, 708-709 Trauma in pregnancy Laparoscopy in pregnancy background, 611-612 complications blunt trauma, 621 entrance techniques, 563-564 abruption, 622 gastrointestinal, 564 delivery rates and modes, 613-614 urinary, 564 fetal monitoring, 621 vascular, 564-565 general management considerations in relation to fetus, 559-560 the obstetric patient, 627-628 gastrointestinal issues general trauma management, 623 appendicitis, 566-567 maternal-fetal outcomes: population-based gallbladder disease, 567 studies, 614-616 gynecologic issues, 565-566 maternal physiology obesity, 560-563 cardiovascular-mediating drugs commonly used physiology and anesthesia, 558-559 in trauma, 617 diagnostic imaging with nonionizing radiation, 619-620 Partnership issues and sexuality, 656-658 imaging in pregnancy, 618-619 creating sex esteem, 663-664 invasive hemodynamic monitoring, 616-617 decline in sexuality over time, 659-660 mechanical ventilation in the pregnant patient, dichotomy in female sexuality, 658-659 617-618 enhancing normal sexuality, 664 utility of Kleihauer-Betke testing in trauma, 618 sexual response circle, 660-662 penetrating trauma, 622-623 primary survey Sexuality and sexual dysfunction, 654-655 airway, 623-624 Sexual pain breathing, 624-625 definitions and characteristics of, 683-684 circulation, 625-626 diagnosis, 685-686 disability, 627 etiology, 684 risk factors, 612 pathophysiology, 684-685 typical mechanisms of trauma-related maternal prevalence, 682-683 injury, 612-613